BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3987208)

  • 21. Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease.
    Jakobsson JKF; Aaltonen HL; Nicklasson H; Gudmundsson A; Rissler J; Wollmer P; Löndahl J
    BMC Pulm Med; 2018 Aug; 18(1):129. PubMed ID: 30081885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clearance in smaller airways of inhaled 6-microm particles in subjects with immotile-cilia syndrome.
    Svartengren K; Philipson K; Svartengren M; Nerbrink O; Camner P
    Exp Lung Res; 1995; 21(5):667-82. PubMed ID: 8556987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man.
    Ilowite JS; Smaldone GC; Perry RJ; Bennett WD; Foster WM
    Arch Environ Health; 1989; 44(4):267-73. PubMed ID: 2782948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model for assessing bronchial mucus transport.
    Agnew JE; Bateman JR; Pavia D; Clarke SW
    J Nucl Med; 1984 Feb; 25(2):170-6. PubMed ID: 6726429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease.
    Meyer T; Müllinger B; Sommerer K; Scheuch G; Brand P; Beckmann H; Häussinger K; Weber N; Siekmeier R
    Exp Lung Res; 2003; 29(7):475-84. PubMed ID: 14710439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the regional deposition of inhaled particles in man.
    Chamberlain MJ; Morgan WK; Vinitski S
    Clin Sci (Lond); 1983 Jan; 64(1):69-78. PubMed ID: 6822051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The topography of particle deposition in the human lung.
    Pityn P; Chamberlain MJ; Fraser TM; King M; Morgan WK
    Respir Physiol; 1989 Oct; 78(1):19-29. PubMed ID: 2813985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of regional deposition of inhaled particles in human lungs by serial bolus delivery method.
    Kim CS; Hu SC; DeWitt P; Gerrity TR
    J Appl Physiol (1985); 1996 Nov; 81(5):2203-13. PubMed ID: 8941546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human alveolar deposition of 4 micron teflon particles.
    Camner P; Philipson K
    Arch Environ Health; 1978; 33(4):181-5. PubMed ID: 686844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human deposition and clearance of 6-micron particles inhaled with an extremely low flow rate.
    Anderson M; Philipson K; Svartengren M; Camner P
    Exp Lung Res; 1995; 21(1):187-95. PubMed ID: 7729377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery.
    Möller W; Felten K; Sommerer K; Scheuch G; Meyer G; Meyer P; Häussinger K; Kreyling WG
    Am J Respir Crit Care Med; 2008 Feb; 177(4):426-32. PubMed ID: 17932382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional mucociliary removal of inhaled particles in smokers with small airways disease.
    Weiss T; Dorow P; Felix R
    Respiration; 1983; 44(5):338-45. PubMed ID: 6622852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial airway deposition and retention of particles in inhaled boluses: effect of anatomic dead space.
    Bennett WD; Scheuch G; Zeman KL; Brown JS; Kim C; Heyder J; Stahlhofen W
    J Appl Physiol (1985); 1998 Aug; 85(2):685-94. PubMed ID: 9688747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract.
    Stahlhofen W; Gebhart J; Heyder J
    Am Ind Hyg Assoc J; 1980 Jun; 41(6):385-98a. PubMed ID: 7395752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimum peripheral drug deposition in patients with cystic fibrosis.
    Brand P; Meyer T; Häussermann S; Schulte M; Scheuch G; Bernhard T; Sommerauer B; Weber N; Griese M
    J Aerosol Med; 2005; 18(1):45-54. PubMed ID: 15741773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonuniformity of diffusing capacity from small alveolar gas samples is increased in smokers.
    Cotton DJ; Mink JT; Graham BL
    Can Respir J; 1998; 5(2):101-8. PubMed ID: 9707452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of aerosol penetration for lung mucociliary clearance studies.
    Agnew JE; Bateman JR; Watts M; Paramananda V; Pavia D; Clarke SW
    Chest; 1981 Dec; 80(6 Suppl):843-6. PubMed ID: 7307623
    [No Abstract]   [Full Text] [Related]  

  • 38. Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked.
    Vastag E; Matthys H; Köhler D; Gronbeck L; Daikeler G
    Eur J Respir Dis Suppl; 1985; 139():93-100. PubMed ID: 3862617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased fine particle deposition in women with asymptomatic nonspecific airway hyperresponsiveness.
    Kohlhäufl M; Brand P; Scheuch G; Meyer TS; Schulz H; Häussinger K; Heyder J
    Am J Respir Crit Care Med; 1999 Mar; 159(3):902-6. PubMed ID: 10051270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alveolar deposition of inhaled radio-aerosol particles in central and peripheral airway obstruction. Methodologic conditions and clinical results].
    Weiss T; Dorow P; Felix R
    Rofo; 1983 Jun; 138(6):716-21. PubMed ID: 6407936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.